Replies to post #215000 on Biotech Values

[DewDiligence]

SNN acquires OSIR for $19/sh in cash—a 1% premium to yesterday’s close:

https://www.globenewswire.com/news-release/2019/03/12/1751859/0/en/Osiris-Therapeutics-Inc-Enters-Agreement-to-be-Acquired-by-Smith-Nephew-plc.html

The nominal deal value is $660M.